 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
This scientific program is designed to provide surgeons with an in-depth and up-to-date knowledge relative to surgery for diseases of the colon, rectum and anus with emphasis on patient care, teaching and research. The purpose of all sessions is to improve the quality of care of patients with diseases of the colon and rectum. Educational Objectives At the conclusion of this web cast, participants should be able to: discuss the role of surgery in F.A.P. and the selection of restorative proctocoloectomy vs. subtotal colectomy discuss the utility of the complete clinical response concept following neoadjuvant therapy in the treatment of rectal cancer acknowledge the negative influence of young age on the prognosis of rectal cancer • clarify the pattern of recurrence after laparoscopic coloctomy compared to open colectomy • discuss the technical steps and results of AFP insertion • understand the potential for stool DNA testing as a potential screening method for colorectal cancer • evaluate fecal incontinence and understand the importance of the fecal incontinence severity index • assess the need for fecal diversion in patients with penetrating rectal trauma Accreditation The American Society of Colon and Rectal Surgeons (ASCRS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Continuing Medical Education Credit The ASCRS designates this education activity for a maximum of 23 hours of AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Disclosure Presenters were requested to disclose relevant financial relationships with commercial interests as well as FDA clearance status of all pharmaceutical and medical devices which would be discussed prior to their presentation. Disclosure can be found at the beginning of each on-line presentation. Goals The goals of these CME programs are to improve the prevention, diagnosis and treatment of patients with diseases and disorders affecting the colon and rectum; and improve the quality of patient care by maintaining, developing and enhancing the knowledge, skills, professional performance and multi-disciplinary relationships necessary to provide services for patients, the public and the profession. Target Audience This program is intended for the education of colon and rectal surgeons, as well as general surgeons and others in the treatment of diseases affecting the colon and rectum. Minimum System Requirements To assure the optimal viewing experience, please click here to review the systems requirement information before viewing the presentations listed below. Directions to the Learner This is a complimentary activity consisting of an introduction/overview and 10 sessions from the 2006 ASCRS Annual Meeting. Learning assessment and evaluation forms follow each session. The learner may participate (view presentation, complete CME test and evaluation) in as many or as few sessions as they would like. To complete this activity and receive CME credit of the Physician's Recognition Award of the American Medical Association, the learner must: 1) Familiarize him/herself with the information on this page; 2) Listen to all presentations in each session you wish to receive CME credit; 3) Complete and pass the test at the end of the session with a score of at least 70%; 4) Complete an evaluation form at the end of each session; Mail the quiz results and evaluation form for each session you wish to receive CME credit to the ASCRS at the following address: American Society of Colon & Rectal Surgeons Attention CME Department 85 W. Algonquin Rd., Suite 550 Arlington Heights, IL 60005 This activity is webcast November, 2006, and CME credit can be earned through October, 2007. Privacy Statement The American Society of Colon & Rectal Surgeons is committed to maintaining the privacy of the personal information of visitors to its sites. Our policies are designed to disclose the information collected and how it will be used. This policy applies solely to the information provided while visiting this Web site. The terms of the privacy policy do not govern personal information furnished through any means other than this Web site (such as by telephone or mail). Agreement All images contained in this presentation are copyrighted by the American Society of Colon & Rectal Surgeons. CME credit will not be provided to physicians who have already received credit from attending these sessions at the 2006 ASCRS Annual Meeting. If you have questions regarding CME credit, please contact the American Society of Colon and Rectal Surgeons at ascrs@fascrs.org Disclaimer The primary purpose of the ASCRS Annual Meeting and this web cast is education. Information, as well as technologies, products and/or services discussed, are intended to inform participants about the knowledge, techniques and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exist in the specialty and the views of the American Society of Colon & Rectal Surgeons disclaims any and all liability for damages to any individual participating in this web cast activity for all claims which may result from the use of information, technologies, products and/or services discussed.
Saturday, June 3, 2006 How to Get A Grant Workshop & How to Get Published on the Podium Workshop Objectives: At the conclusion of this session, participants should be able to: 1) navigate the system of grant mechanisms; 2) know how to get started writing a grant; 3) understand how to write content for grants; 4) understand the process once grants are submitted; 5) know the mechanisms involved in revising and resubmitting grant requests; 6) understand the important elements of drafting manuscripts and abstracts; 7) know how to get started writing a manuscript or abstract; 8) understand how to avoid common pitfalls when writing abstracts and manuscripts; 9) understand the process for consideration of abstracts for presentation and manuscripts for publication once submitted; and 10) know the mechanisms involved in revising and resubmitting manuscripts for publication. NIH/NCI Presented by: Roy Wu, MD View Presentation (Windows Compatible) ASCRS Research Foundation Presented by: David Rothenberger, MD View Presentation (Windows Compatible) Crohn’s and Colitis Foundation, American College of Surgeons, American Cancer Society, ASCO, SSO Presented by: Arden Morris, MD View Presentation (Windows Compatible) How to Get Started Writing a Grant Presented by: Jose Guillem, MD View Presentation (Windows Compatible) Basic Science Presented by: Scott Strong, MD View Presentation (Windows Compatible) Clinical Science Presented by: Larissa Temple, MD View Presentation (Windows Compatible) Once Submitted, What is the Process? Presented by: Kelli Bullard Dunn, MD View Presentation (Windows Compatible) Regroup/Revised/Resubmit Presented by: Julio Garcia-Aguilar, MD View Presentation (Windows Compatible) Start with the End in Mind - Consider the Product When Planning the Research Presented by: Robert Beart, MD View Presentation (Windows Compatible) Writing an Effective Abstract - Avoid Critical Errors and Consider the Selection Process Presented by: James Church, MD View Presentation (Windows Compatible) Writing a Winning Manuscript - Content Presented by: Robert Madoff, MD View Presentation (Windows Compatible) Packaging Your Product - Style Presented by: John Pemberton, MD View Presentation (Windows Compatible) Select Your Audience - What Meeting? What Journal? Presented by: Nancy Baxter, MD View Presentation (Windows Compatible) Once Submitted, What’s the Process? Presented by: Susan Galandiuk, MD View Presentation (Windows Compatible) Panel Discussion View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 4 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association.   ^Table of Contents Sunday, June 4, 2006 Core Subject Update Objectives: At the conclusion of this session, participants should be able to: 1) understand the genetic mutations underlying F.A.P., attenuated F.A.P. and myh-associated polyposis as well as genotype-phenotype relationships; 2) understand genetic testing and its pitfalls; 3) understand the role of surgery in F.A.P. and the selection of restorative proctocolectomy vs. subtotal colectomy; and 4) understand screening and surveillance of both the colon and duodenum in at-risk individuals. Fissures / Pruritus Presented by: Jan Rakinic, MD View Presentation (Windows Compatible) Familial Adenomatous Polyposis Presented by: David Dietz, MD, View Presentation (Windows Compatible) Volvulus Presented by: Lawrence Yee, MD View Presentation (Windows Compatible) Trauma Presented by: Jose Cintron, MD View Presentation (Windows Compatible) IBD - Medical Management Presented by: Eric Dozois, MD View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 2.5 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ^Table of Contents Rectal Cancer I & Joseph M. Mathews Oration Objectives: Upon completion of this session, participants should be able to: 1)) identify clinicopathologic factors associated with response to combined modality therapy for rectal cancer; 2) discuss the utility of the complete clinical response concept following neoadjuvant therapy in the treatment of rectal cancer; 3) analyze the value of the PET scan in evaluating distal rectal cancer especially when non-operative treatment following neoadjuvant chemoradiation therapy is considered; 4) include endocavitary radiation in the treatment options for early stage rectal cancers; and 5) understand the potential uses of TEM for local excision of rectal cancer. Predictive Clinicopathologic Factors for Limited Response of T3 Rectal Cancer to Combined Modality Therapy Presented by: AY Lin, WD Wong, LK Temple, J Shia, BD Minsky, JG Guillem, PB Paty, MR Weiser View Presentation (Windows Compatible) What is a Complete Clinical Response to Neoadjuvant Therapy for Rectal Cancer? Results of a Meta-analysis Presented by: L. Santiago, J. Marcet, J. Cromwell View Presentation (Windows Compatible) Non-operative Treatment of Distal Rectal Cancer after Complete Tumor Regression Following Neoadjuvant Chemoradiation – Late Assessment of Local Control by Petscan Presented by: I. Proscurshim, R. Perez, A. Habr-Gama, D. Kiss, G. SaoJuliao, A.Imperiale, C.Buchpiguel, J. Gama-Rodrigues View Presentation (Windows Compatible) Endocavitary Radiation for Rectal Cancer: Analysis of Prognostic Factors and Outcomes for 274 Patients Presented by: S. Hunt, G. Banet, R. Meyerson, J. Fleshman, E. Birnbaum, D.Dietz, M. Mutch, J.Lowney, P. Grigsby, I. Kodner View Presentation (Windows Compatible) Transanal Endoscopic Microsurgery (TEM) Improves Outcome in Local Treatment of Early Rectal Cancer Presented by: M. Dixon, C. Finne, R. Madoff, J. Goldberg, A. Mellgren, K. Alavi, View Presentation (Windows Compatible) Joseph M. Mathews Oration: 2,435 Publications Later: A 10-year Odyssey with DC&R Presented by: Victor W. Fazio, MD View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 1.5 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ^Table of Contents Expert Panel: Local Therapy of Rectal Cancer Objectives: At the conclusion of this panel, participants should understand the oncologic and functional outcomes following local excision of rectal adenocarcinoma. Oncologic Outcomes: Local Excision versus Proctectomy Presented by: Nancy Baxter, MD View Presentation (Windows Compatible) Will Better Staging Improve Outcomes? Presented by: Douglas Wong, MD, View Presentation (Windows Compatible) Will Adjuvant Chemoradiotherapy Improve Outcomes? Presented by: Julio Garcia-Aguilar, MD View Presentation (Windows Compatible) Functional Outcomes: Local Excision versus Proctectomy Presented by: Peter Cataldo, MD View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 1.25 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ^Table of Contents Monday, June 5, 2006 Rectal Cancer II Objectives: Upon completion of this session, participants should be able to: 1) acknowledge the negative influence of young age on the prognosis of rectal cancer; 2) note that the rate of sphincter sparing surgery has increased over the study period although the majority of radical resections for rectal cancer in the U.S. continue to require a permanent colostomy and the absolute number of APR procedures performed remains high. In addition, participants will note that the increase in sphincter sparing surgery remains disproportionately low among blacks, males, patients with Medicaid insurance, and patients in lower income zip codes; 3) assess the postoperative results of rectal cancer surgery in patients without preoperative bowel preparation; 4) understand the difference in outcomes in laparoscopic resection for extra-peritoneal rectal cancer; 5) understand the indication of laparoscopic surgery in rectal cancer patients; criteria to perform an evaluation of quality of life and how cost-benefit analysis should be carried out; 6) describe differences in clinical course between HIV+ and HIV- anal cancer patients; 7) management of primary obstructive colonic cancer with unresectable metastases; and 8) understand the role of hypoxia and angiogenesis in rectal cancer, specifically understand the role of hypoxia-inducible 1-± and hypoxia-inducible 2-± in the hypoxic response to tumor growth in rectal cancer; understand the relationship between hypoxic factors and prognosis in rectal cancer. Rectal Cancer in the Young Patient Presented by: B. Endreseth, P. Romundstad, H. Myrvold, U. Hestvik, T.Bjerkeset, A. Wibe View Presentation (Windows Compatible) Does Reality Reflect Best Practice for Rectal Cancer Surgery? Presented by: R. Ricciardi, B. Virnig, R. Madoff, D. Rothenberger, N. Baxter View Presentation (Windows Compatible) Rectal Cancer Surgery without Mechanical Bowel Preparation: Results of a Case-control Study Presented by: Y. Panis, F. Bretagnol, A. Alves, C. Hennequin, P. Valleur View Presentation (Windows Compatible) Laparoscopic Resection of Extra – vs. Intraperitoneal Rectal Cancer Presented by: S. Kim, I. Park, Y. Joh, K. Hahn View Presentation (Windows Compatible) Laparoscopic Resection in Rectal Cancer Patients: Outcome and Cost Benefit Analysis Presented by: M. Braga, M. Frasson, A. Vignali, W. Zuliani, V. Civelli, V. Di Carlo View Presentation (Windows Compatible) Squamous Cell Carcinoma of Anal Canal – A Changing Entity in the Era of HIV Disease Presented by: R. Kundu, D. Nagle, D. Henry, F. Nichini and M, Haber View Presentation (Windows Compatible) Self-expending Metallic Stents Should be the First Step to Treat Obstructing Primary Colonic Cancer with Unresectable Metastases Presented by: J. Loriau, M. Karoui, A. Charachon, C. Delbaldo, F. Brunetti, C. Tayar, A. Laurent, J. Tran Van Nhieu, I. Sobhani, J. Delchier, P. Piedbois, D. Cherqui, P. Fagniez View Presentation (Windows Compatible) Hypoxia-inducible Factor 1-a (HIF-1a) and Hypoxia-inducible Factor 2-a (HIF-2a) Expression, Angiogenesis and Relationship to Prognosis in Rectal Cancer Patient Presented by: S. Rasheed, A. Harris, P. Tekkis, H. Turley, A. Silver, V. Johnson, P. McDonald, I. Talbot, R. Glynne- Jones, J. Northover, T. Guenther View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 1.25 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ^Table of Contents Colorectal Cancer & Presidential Address Objectives: Upon completion of this session, participants should be able to: 1) analyze the extended long-term oncologic ramifications of a minimally invasive approach to cancers of the colon and rectum; develop treatment options for patients with cancer of the colon and rectum; 2) analyze the current data available reporting oncologic equivalence between a minimally invasive approach and conventional approach for the treatment of cancer of the colon and rectum; 3) clarify the pattern of recurrence after laparoscopic colectomy compared to open colectomy; 4) analyze the difference in outcomes for colon cancer based on number of lymph nodes examined; critically assess the importance of an adequate lymph node dissection for node negative early stage tumors; 5) understand the potential uses for this technology for colon cancer screening; 6) analyze the clinical significance of the phenotypic differences in new mutation FAP patients; provide appropriate counseling and treatment for those patients based in the evidences; 7) determine the level of risk of desmoids in an individual FAP patient; counsel that patient regarding level of risk; 8) analyze the difference in the outcome of low colorectal or colo-anal anastomosis with and without reinforcement by regenerated oxidized cellulose; challenge the idea of diversion after colo-anal anastomosis in neoplastic diseases; 9) be aware that elevated PDGF levels are seen in patients with colonic adenocarcinoma and the extent of the elevation correlates with the severity of disease. A Prospective Randomized Trial Comparing Laparoscopic vs. Open Colectomy for Cancer: A 10-year Follow-up Presented by: D. Geisler, J. Milsom, T. Hull, P. Marcello, J. Hammel, K. Brady, V. Fazio View Presentation (Windows Compatible) The Pattern of Recurrence after Laparoscopic Colectomy for Colon Cancer: A Matched Case-control Study Presented by: K. Okabayashi, H. Hasegawa, H. Nishibori, Y. Ishii, T. Endo, M. Watanabe, M. Katajima View Presentation (Windows Compatible) Should < 12 Nodes Removed be Considered Substandard Care for All Colon Cancer Patients? Presented by: M. Maggard, M. McGory, J. Tomlinson, C. Ko View Presentation (Windows Compatible) Novel Optics Technology for Detecting Field Carcinogenesis in Colorectal Cancer Presented by: J. Muldoon, Y. Kim, Y. Liu, V. Turzhitsky, M. Jameel, N. Hasabou, H. Roy, V. Backman View Presentation (Windows Compatible) There is Something About a New Mutation that Causes Severe Disease in FAP: A Comparative Study of Probands Stratified by Family History Presented by: M. Bonardi, K. Bova, L. LaGuardia, E. Manilich, J. Church View Presentation (Windows Compatible) Can Desmoids be Predicted? The Use of Knowledge Discovery Techniques in Familial Adenomatous Polyposis Presented by: J. Church, E. Manilich, L. LaGuardia, K. Bova View Presentation (Windows Compatible) Oxidized Cellulose Reinforcement of Low Rectal Anastomosis: Do We Still Need Diversion? Presented by: K. Madbouly, G. Gwifal, A.Hussein View Presentation (Windows Compatible) PDGF is Elevated in Patients with Colonic Adenocarcinoma Presented by: A. Belizou, E. Balik, S. Jain, P. Horst, V. Cekic, T. Arnell, D. Feingold, R. Whelan View Presentation (Windows Compatible) Presidential Address: The Road Not Taken Presented by: Ann C. Lowry, MD View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 1.75 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ^Table of Contents Frontiers in Colorectal Surgery Objectives: At the conclusion of this session, participants should be able to: 1) review areas of innovation in surgical techniques with a focus on technological advances; 2) examine recent advances in experimental (laboratory) technical innovations; and 3) review the ability for surgical simulation to provide objective assessment of surgical skills. The Future of Robotic Surgery Presented by: Richard Satava, MD View Presentation (Windows Compatible) The Future of Natural Orifice Surgery Presented by: Lee Swanstrom, MD View Presentation (Windows Compatible) Intraluminal Endoscopic Frontiers Presented by: Kenneth Chang, MD View Presentation (Windows Compatible) Surgical Simulators – Is it for Real? Presented by: Richard Reznick, MD View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 1.5 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ^Table of Contents Laparoscopy & Colonoscopy & Memorial Lectureship Objectives: Upon completion of this session, participants should be able to: 1)recognize the implications of using Entonox for sedation during colonoscopy; 2) identify and enumerate the significant risk of advanced colorectal neoplasia associated with large hyperplastic polyps; develop a plan of managing large hyperplastic polyps endoscopically both by intervention and surveillance; 3) learn of the new diagnostic technique of autofluorescence endoscopy and it's potential to differentiate between metaplastic and adenomatous polyps; 4) recognize the importance of adenoma detection rate as an index of quality in colonoscopy; 5) analyze the present state of laparoscopic colorectal experience in general surgery and colorectal residency; 6) recognize the educational value of training for laparoscopic colon resection in an instructional course with a cadaver model; and 7) understand the indications and contraindications for laparoscopic approach. Entonox is Superior to Intravenous Sedation for Colonoscopy: A Randomized Controlled Trial Presented by: S. Maslekar, A. Gardiner, M. Hughes, E. Skinn, B. Culbert, G. Duthie View Presentation (Windows Compatible) Large Hyperplastic Polyps: Wolves in Sheeps’ Clothing? Presented by: M. Kalady, J. Church View Presentation (Windows Compatible) Evaluation of Autofluorescence Colonoscopy for the Detection and Diagnosis of Colonic Polyps Presented by: A. McCallum, J. Jenkins, D. Gillen, R. Molloy View Presentation (Windows Compatible) Adenoma Detection Rate: The Real Indicator of Quality in Colonoscopy Presented by: M. Millan, P. Gross, E. Manilich, J. Church View Presentation (Windows Compatible) The Gap in Laparoscopic Colorectal Experience between ASCRS Fellowship and General Surgery Residency Training Programs Presented by: P. Charron, J. Gallagher, S. DeJesus, A. Ferrara View Presentation (Windows Compatible) Adoption of Laparoscopic Colectomy: Results and Implications of ASCRS Hands-on Course Participation Presented by: H. Ross, P. Marcello, D. Rivadeneira, C. Simmang, J. Fleshman View Presentation (Windows Compatible) Laparoscopic Colorectal Surgery in Patients with Major Pulmonary Co-morbidities Presented by: I. Okereke, D. Geisler, T. Garofalo, F. Remzi, L. Stocchi, J. Vogel, E. Manilich, V. Fazio View Presentation (Windows Compatible) Memorial Lectureship honoring James A. Ferguson, MD - Facing Future Responsibilities Presented by: John MacKeigan, MD View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 1.75 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ^Table of Contents Advanced Colonoscopy: Beyond the Search for Polyps Objectives: At the conclusion of this session, participants should be able to: 1) understand advanced polypectomy techniques such as saline assisted polypectomy and piecemeal excison; 2) understand the indications and published results with intraluminal colonic stents and dilatation; and 3) describe methods to endoscopically control colonic hemorrhage and 4) discuss chromoscopy and magnification colonoscopy. Advanced Polypectomy Techniques Presented by: John A. Coller, MD View Presentation (Windows Compatible) Colonic Stents and Dilatation Presented by: W. Brian Sweeney, MD View Presentation (Windows Compatible) Control of Bleeding (Acute and Chronic) Presented by: Charles B. Whitlow, MD View Presentation (Windows Compatible) Chromoscopy and Magnification Presented by: David E. Beck, MD, View Presentation (Windows Compatible) Panel Discussion View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 1.5 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ^Table of Contents Tuesday, June 6, 2006 Anorectal & Ernestine Hambrick Lectureship Objectives: Upon completion of this session, participants should be able to: 1) understand the technical steps and results of AFP insertion; 2)determine whether the duration of a draining seton influences the outcome of a subsequent advancement flap; 3) the purpose of the present study was to evaluate the success rate of a repeat transanal advancement flap repair and to assess the impact of such a second procedure on the overall healing rate of high trans-sphincteric fistulas and on fecal continence; 4) describe the difference in presentation of MRSA positive perianal abscesses versus MRSA negative abscesses; 5) understand the technique for and results of treating anal squamous intraepithelial neoplasia with the infrared coagulator; understand the superiority of results in HIV-negative patients as opposed to HIV-positive patients; 6) analyze the long term results after PPH and correlate them with Milligan-Morgan procedure; 7) appreciate at least two factors that can improve outcome after primary repair of Obstetric sphincter injuries; and 8) understand the importance of physiological study in patients with anal fissure; anal pressures can be reduced by treating the fissure and not cutting the muscle. Efficacy of Anal Fistula Plug in Closure of Complex Cryptoglandular Anal Fistula Presented by: B. Champagne, L. O’Connor, M. Schertzer, D. Armstrong View Presentation (Windows Compatible) The Duration of Indwelling Draining Setons Influences the Outcome of Subsequent Advancement Flaps in the Treatment of Complex Perianal Fistulas Presented by: B. Person, D. Sands, E. Weiss, S. Wexner, J. Nogueras View Presentation (Windows Compatible) Impact of Repeat Transanal Advancement Flap Repair on the Overall Healing of High Transsphincteric Fistulas Presented by: L. Mitalas, M. Gosselink, D. Zimmerman, W. Schouten View Presentation (Windows Compatible) MRSA-related Perianal Abscesses: An Under-recognized Disease Entity Presented by: J. Albright, M. Snyder, M. Pidala, J. Cali, H. Bailey View Presentation (Windows Compatible) Infrared Coagulator Ablation of High-grade Anal Squamus Intraepithelial Lesions in HIV-Negative Men who Have Sex with Men Presented by: S. Goldstone, J. Hundert, J.Huyett View Presentation (Windows Compatible) PPH and Milligan Morgan in the Cure of Hemorrhoids: Long Term Evaluation and Clinical Results Presented by: C. Mattana, C. Coco, A. Manno, A. Verbo, G. Rizzo View Presentation (Windows Compatible) Operative Technique and Expertise Influence Outcome after Primary Repair for Obstetric Sphincter Injury Presented by: J. Nordenstam, J. Zetterstron, A. Lopez, C. Johansson, B. Anzen S. Parker, A. Mellgren View Presentation (Windows Compatible) Manometric Analysis of Anal Pressures in Patients with Chronic Anal Fissure Treated with and without Sphincterotomy: A Prospective Randomized Comparative Study Presented by: O. Oliveira, M. Bonardi, R.Bonardi View Presentation (Windows Compatible) Ernestine Hambrick Lectureship: Past, Present & Future of Colon & Rectal Cancer Screening Presented by: Lester Rosen, MD View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 1.75 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ^Table of Contents Maintenance of Certification Maintenance of Certification - Update Presented by: Martin Luchtefeld, MD View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 0.5 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ^Table of Contents Wednesday, June 7, 2006 Pelvic Floor & Humanities Lecture Objectives: Upon completion of this session, participants should be able to: 1) determine and understand the significance of using sacral nerve neuromodulation as primary treatment of fecal incontinence secondary to disrupted anal sphincters; 2) understand the role of injectable silicone biomaterial in treating passive fecal incontinence; understand the role of reinjection of injectable silicone biomaterial for passive fecal incontinence; 3) decide the best management for women with fecal incontinence due to obstetric sphincter injury; 4) evaluate fecal incontinence and understand the importance of the fecal incontinence severity index; 5) determine the effect of fecal incontinence (FI) severity and associated symptoms on FI-specific quality of life; 6) updated on results, complications and contraindications of this new procedure; 7) understand the difference in outcome between transperineal and transrectal repair of rectocele and decide which one to use in each case; and 8) identify those factors which contribute to the functional outcome after CPA. Sacral Nerve Stimulation as Primary Treatment for Fecal Incontinence Secondary to Obstetric Anal Sphincter Damage: Medium and Long-term Results Presented by: S. Maslekar, A. Gardiner, G. Duthie View Presentation (Windows Compatible) Long-term Results of Injectable Silicone Biomaterial for Passive Fecal Incontinence - A Randomized Trial Presented by: J. Tjandra, J. Tan, J. Lim, C. Murray-Green View Presentation (Windows Compatible) Outcome of Surgical vs. Nonsurgical Management of Fecal Incontinence Due to Obstetric Sphincter Injury Presented by: S. Sucar, N. Baxter, A. Lowry, A. Mellgren, S. Parker View Presentation (Windows Compatible) Does Incontinence Severity Correlate with Quality of Life? Presented by: L. Bordeianou, T. Rockwood, A. Lowry, N. Baxter, A. Mellgren, S. Parker View Presentation (Windows Compatible) Health-related Quality of Life in Patients Presenting for Evaluation of Fecal Incontinence Presented by: S. Perretta, J. Wang, T. Patterson, S. Hart, M. Varma View Presentation (Windows Compatible) Factors Predicting Outcome after Stapled Transanal Rectal Resection (STARR) Procedure for Obstructed Defecation Presented by: G. Gagliardi, G. Binda, C. Bottini, G. Dodi, V. Filingieri, G. Milito, M. Rinaldi, G. Romano, M.Trompetto, M. Pescatori View Presentation (Windows Compatible) Transperineal vs Trans-rectal Repair of Rectocele in Obstructed Defecation: A Prospective Randomized Trial Presented by: K. Madbouly, M. Farid, T. Mahdy, A. Hussein View Presentation (Windows Compatible) Impact of Neo-rectal Wall Properties on Functional Outcome after Colonic J-pouch Anal anastomosis Presented by: M. Gosselink, D. Zimmerman, W. Hop, W. Schouten View Presentation (Windows Compatible) Parviz Kamangar Humanities in Surgery Lectureship: Surgeons’ Disclosure of Harmful Errors to Patients: What is the Data Telling Us Presented by: Thomas H. Gallagher, MD View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 1.25 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ^Table of Contents Benign Colorectal Objectives: Upon completion of this session, participants should be able to: 1) develop a plan for implementation of a protocol targeting surgical site infection in colorectal surgery; 2) identify risk factors for anastomotic leak following right-sided colonic anastomoses; 3) assess the value of a predictive score of mortality after colorectal surgery; 4) critically assess the role of percutaneous drainage in the management of patients with Hinchey stage II diverticulitis; 5) appreciate the short-term safety and efficacy as well as long-term durability of super-selective embolization in the treatment of lower GI bleeding; 6) understand the risks of ischemic colitis following endovascular repair of abdominal aortic aneurysm; 7) identify the significant impact of colon and rectal injuries in terms of morbidity and mortality in the trauma patient; identify the prevalence, location, and associated injuries, and stomal prevalence in the patient with colon and rectal injuries; identify independent associations of colon and rectal injuries with both mortality and leak rates; and 8) assess the need for fecal diversion in patients with penetrating rectal trauma. Efficacy of Protocol Implementation on the Incidence of Surgical Site Infection in Colorectal Surgery Presented by: T. Hedrick, J. Heckman, R.Sawyer, C. Friel, E. Foley View Presentation (Windows Compatible) Risk Factors for Anastomotic Leak Following Right-sided Colonic Anastomoses Presented by: N. Raju, B. Teng, V, Kirchner, J. Trudel View Presentation (Windows Compatible) The “AFC-score”: Validation of a Four-item Predicting Score of Postoperative Mortality after Colorectal Surgery: Results of a Prospective Multicenter Study in 1049 Patients Presented by: Y. Panis, A. Alves, E. Vicaut, K. Slim, F. Kwiatkowski, G.Mantion View Presentation (Windows Compatible) Percutaneous CT Scan-guided Drainage vs. Antibiotherapy Alone for Hinchey Stage II Diverticulitis: A Case-control Study Presented by: P. Gervaz, D. Brandt, P. Poletti, Y. Durmishi, P. Morel View Presentation (Windows Compatible) The Efficacy and Durability of Super-selective Embolization in the Treatment of Lower Gastrointestinal Bleeding Presented by: T. Lipof, J. Cohen, C. Bartus, K. Johnson, W. Sardella, P.Vignati View Presentation (Windows Compatible) Decreased Incidence of Colonic Ischemia after Repair of Ruptured Abdominal Aortic Aneurysms with Endograft Presented by: B. Champagne, E. Lee, B.Valerian View Presentation (Windows Compatible) Colorectal Injuries during Operation Iraqi Freedom: Are There Changes in Management or Outcomes? Presented by: S. Steele, P. Mullenix, M. Martin, J. Sebesta, K. Azarow, A. Beekley View Presentation (Windows Compatible) Management of Penetrating Injuries of the Extraperitoneal Rectum without Fecal Diversion Presented by: K. El-Badawi, R. Gonzalez, H. Phelan, M. Hasson, C. Rodning, C. Ellis View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 1.25 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ^Table of Contents Inflammatory Bowel Disease Objectives: Upon completion of this session, participants should be able to: 1) understand the implications of indeterminate for dysplasia and formulate a management plan for these patients; 2) appreciate the risk of pre-operative use of immunomodulation steroids) in ileo-anal pouch surgery; 3) analyze factors that may be predictive of early readmission to hospital following IPAA; 4) understand those circumstances when omission of an ileostomy may be appropriate at the time of IPAA; 5) analyze the perioperative risk associated with remicade in patients undergoing ieal pouch-anal anastomosis; 59)discuss the role of NOD2 mutation in the development of pouchitis; 6)recognize perineal Crohn's disease on examination and counsel patients accordingly; adjust their treatment of patients with perianal Crohn's disease according to findings on examination and biopsy; 7) understand the pathophysiology of Peristomal Pyoderma Gangrenosum; and 8) understand that there are multiple treatment modalities for Pyoderma Gangrenosum. Indefinite for Dysplasia, What Next? Presented by: Mavanur, C. Bartus, J. Cohen, P. Vignati, R. Williams, W.Sardella, K. Johnson View Presentation (Windows Compatible) Impact of Pre-operative Immunomodulation on Ileal-pouch Anal Anastomosis Sepsis Presented by: M. Lim, A. Abdulgader, D. Thekkinkatti, P. Finan, P. Sagar, D. Burke View Presentation (Windows Compatible) High Hospital Readmission Rates following Ileal Pouch-Anal Anastomosis Presented by: I. Datta, D. Buie, A. MacLean, J. Heine View Presentation (Windows Compatible) To Divert or Not to Divert: A Propensity Model for Omission of Ileostomy in Ileal Pouch Surgery Presented by: P. Tekkis, R. Lovegrove, F. Remzi, A. Heriot, H. Tilney, T. Hull,S. Strong, J. Church, R. Nicholls, V. Fazio View Presentation (Windows Compatible) Does Infliximab Influence Surgical Morbidity of Ileal Pouch-Anal Anastomosis in Patients with Ulcerative Colitis? Presented by: S. Schluender, E. Vasiliauskas, M. Dubinsky, K. Papadakis, A. Ippoliti, S. Targan, P. Fleshner View Presentation (Windows Compatible) Increased Presence of NOD2 Mutations in Patients with Pouchitis after Ileal Pouch Anal Anastomosis for Ulcerative Colitis Presented by: L. Poritz, J. Thompson, A. Dowell, W. Koltun View Presentation (Windows Compatible) Beware Perineal Crohn's Disease! An Indicator of Poor Prognosis and Potential Proctectomy Presented by: R. Figg, J. Church View Presentation (Windows Compatible) Peristomal Pyoderma Gangrenosum Cromolyn Sodium As An Effective Treatment Modality Presented by: LS Valdez-Boyle, LE Smith, TJ Stahl, JM Ayscue, A Mathew View Presentation (Windows Compatible) Consultant's Corner: Inflammatory Bowel Disease Presented by: P. Marcello, S. Strong, J. Terdiman, B. Wolff View Presentation (Windows Compatible) ASCRS designates this continuing medical education activity for 1.25 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association. ^Table of Contents
Copyright © 2006 American Society of Colon and Rectal Surgeons. All rights reserved. The listings and contents of this page are proprietary and cannot be reproduced in any format without written permission from the copyright holder. ASCRS is not responsible and assumes no liability for the content or quality of any of the documents or the software contained on this page,or any errors, claims or discrepancies they may contain.Objectives:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
